DOLBY MEDICAL EBT TRUSTEE LIMITED
DOLBY MEDICAL EBT TRUSTEE LIMITED
DOLBY MEDICAL EBT TRUSTEE LIMITED
Company Registration Number:
SC475115 (Scotland)
Unaudited statutory accounts for the year ended 31 March 2023
Period of accounts
Start date: 1 April 2022
End date: 31 March 2023
DOLBY MEDICAL EBT TRUSTEE LIMITED
Contents of the Financial Statements
for the Period Ended 31 March 2023
Directors report | |
Balance sheet | |
Additional notes | |
Balance sheet notes |
DOLBY MEDICAL EBT TRUSTEE LIMITED
Directors' report period ended
The directors present their report with the financial statements of the company for the period ended 31 March 2023
Principal activities of the company
Additional information
Business reviewReview of the development and performance of the company The Company is a member of the group of companies headed by Phey Bidco Limited (‘the Group’). The principal activities of the Group is the provision of materials, services and equipment to dental practices. The Group is a leading supplier of dental and other medical consumables, materials, medical aesthetics and services (including the installation and servicing of specialised dental equipment), selling dental supplies and services to at least 8,000 dental practices and 3,000 aesthetic practices.Strategy and future outlook The company is expected to satisfy its remaining obligations to beneficiaries of the EBT in the forthcoming year. Financial review The company made no profit or loss for the years ended 31 March 2023 and 31 March 2022. Principal risks and uncertainties The company’s risks and uncertainties are integrated with the principal risks and uncertainties of the Group. Accordingly, the principal risks and uncertainties of Phey Bidco Limited, which includes those of the Company, are discussed in the Strategic report in the financial statements of Phey Bidco Limited which does not form part of this report. The consolidated financial statements of Phey Bidco Limited are publicly available and may be obtained from Phey Bidco Limited, 6 Perry Way, Witham, Essex, CM8 3SX, United Kingdom.
Directors
The directors shown below have held office during the whole of the period from
1 April 2022 to 31 March 2023
The director shown below has held office during the period of
1 April 2022 to 1 March 2023
The directors shown below have held office during the period of
1 April 2022 to 6 June 2022
Secretary
The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006
This report was approved by the board of directors on
And signed on behalf of the board by:
Name:
Status: Secretary
DOLBY MEDICAL EBT TRUSTEE LIMITED
Balance sheet
As at
Notes | 2023 | 2022 | |
---|---|---|---|
| £ | £ | |
Current assets | |||
Debtors: | 3 | | |
Total current assets: | | | |
Net current assets (liabilities): | | | |
Total assets less current liabilities: | | | |
Total net assets (liabilities): | | | |
Capital and reserves | |||
Called up share capital: | | | |
Total Shareholders' funds: | | |
The notes form part of these financial statements
DOLBY MEDICAL EBT TRUSTEE LIMITED
Balance sheet statements
The directors have chosen not to file a copy of the company's profit and loss account.
This report was approved by the board of directors on
and signed on behalf of the board by:
Name:
Status: Director
The notes form part of these financial statements
DOLBY MEDICAL EBT TRUSTEE LIMITED
Notes to the Financial Statements
for the Period Ended 31 March 2023
-
1. Accounting policies
Basis of measurement and preparation
These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102 Intangible fixed assets amortisation policy
Financial instrumentsBasic financial assets and liabilities, including amounts owed by group undertakings and amounts owed to EBT beneficiaries, in accordance with section 11 and 12 of FRS 102 are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Such assets are subsequently carried at amortised cost using the effective interest method. At the end of each reporting period financial assets measured at amortised cost are assessed for objective evidence of impairment. If an asset is impaired the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in the income statement. If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been had the impairment not previously been recognised. The impairment reversal is recognised in the income statement. Valuation information and policy
Carrying value of financial assets and liabilities At the end of each reporting period, the directors assess the carrying value of financial assets for objective evidence of impairment. In addition, where financial assets or liabilities constitute a financing arrangement, the value of the asset or liability is measured by reference to the present value of the estimated future cash flows. Both of these estimates require the future cash flows arising from the financial assets or liabilities to be estimated and an appropriate discount rate to be selected.
DOLBY MEDICAL EBT TRUSTEE LIMITED
Notes to the Financial Statements
for the Period Ended 31 March 2023
-
2. Employees
2023 2022 Average number of employees during the period 0 0
DOLBY MEDICAL EBT TRUSTEE LIMITED
Notes to the Financial Statements
for the Period Ended 31 March 2023
3. Debtors
2023 | 2022 | |
---|---|---|
£ | £ | |
Other debtors | | |
Total | | |